SARS, MERS and COVID-19, the story continues
Journal of Cellular & Molecular Anesthesia,
Vol. 5 No. 2 (2020),
21 July 2020
,
Page 57-58
https://doi.org/10.22037/jcma.v5i2.31196
Abstract
Although the three viruses corona viruses (SARS-CoV: 2003, MERS-CoV: 2012 and SARS-CoV-2: 2019) have similarities especially regarding clinical features, there are key differences between them that limit the relevance of experiences from previous crises. Regarding treatment in the absence of vaccine, it is recommended an the first stage to use pharmaceuticals and their combinations (protease inhibitors, interferon compounds, antiviral antibodies) aiming to suppress diverse targets during virus propagation and during the second disease stage, it seems crucial and reasonable to rely on administration of pathogenetic drugs to restrict life threatening events resulting in marked inflammation, intoxication, hypoxia and infection. The most important method to prevent viral zoonosis is to maintain the barriers between natural reservoirs and human society.
- SARS;
- MERS;
- COVID-19;
How to Cite
References
- Guarner J. Three Emerging Coronaviruses in Two Decades The Story of SARS, MERS, and Now COVID-19. Am J Clin Pathol April 2020; 153(4): 420-1.
-Gilbert GL. SARS, MERS and COVID-19-new threats; old lessons. Int J Epidemiol. Int J Epidemiol. 2020;dyaa061..
- Cha RH, Joh JS, Jeong I, Lee JY, Shin HS, Kim G, et al. Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015; 30(12):1807-14.
- Kalteh EA, Sofizadeh A, Fararooei M, Ghelichi Ghojogh M, Aljalili S, Measures of Mortality in Coronavirus (COVID-19) Compared with SARS and MERS. J Cell Mol Anesth. 2020;5(2):97-101.
- Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382(12):1177-9.
- Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361: (9371):1767-72.
- Booth CM. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 2003; 289(21):2801-9.
- Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecaleoral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335-7.
- Mahmoodpoor A, Akbarzadeh MA, Sanaie S, Hosseini MS. Role of telehealth in outbreaks-Where the classical healthcare systems fail. Infect Control Hosp Epidemiol. 2020;1-2.
- Golestani-Eraghi M, Mahmoodpoor A. Early application of prone position for management of Covid-19 patients. J Clin Anesth. 2020; 66:109917.
- Mahmoodpoor A, Shadvar K, Ghamari A A , Mohammadzadeh Lameh M , Asghari Ardebili R , et al. Management of Critically Ill Patients with COVID-19: What We Learned and What We Do. Anesth Pain Med. 2020; 10(3):e104900.
- Zhirnov OP. Molecular Targets in the Chemotherapy of Coronavirus Infection. Biochemistry (Mosc). 2020; 85(5):523-30.
- Abstract Viewed: 308 times
- PDF Downloaded: 163 times